<code id='2A17E5DA4E'></code><style id='2A17E5DA4E'></style>
    • <acronym id='2A17E5DA4E'></acronym>
      <center id='2A17E5DA4E'><center id='2A17E5DA4E'><tfoot id='2A17E5DA4E'></tfoot></center><abbr id='2A17E5DA4E'><dir id='2A17E5DA4E'><tfoot id='2A17E5DA4E'></tfoot><noframes id='2A17E5DA4E'>

    • <optgroup id='2A17E5DA4E'><strike id='2A17E5DA4E'><sup id='2A17E5DA4E'></sup></strike><code id='2A17E5DA4E'></code></optgroup>
        1. <b id='2A17E5DA4E'><label id='2A17E5DA4E'><select id='2A17E5DA4E'><dt id='2A17E5DA4E'><span id='2A17E5DA4E'></span></dt></select></label></b><u id='2A17E5DA4E'></u>
          <i id='2A17E5DA4E'><strike id='2A17E5DA4E'><tt id='2A17E5DA4E'><pre id='2A17E5DA4E'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:comprehensive    Page View:189
          Treeline Northwest
          AP Photo/Ted S. Warren

          Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

          Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

          advertisement

          Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more
          Sanofi says it has 12 blockbusters on the way. Will investors believe it?
          Sanofi says it has 12 blockbusters on the way. Will investors believe it?

          SanofiCEOPaulHudsonCourtesySanofiNEWYORK—ThetopexecutivesatFrenchdruggiantSanofionWednesdaydefendedt

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Fertility clinic egg and embryo storage is a disaster

          Samplesofembryos,eggs,andspermcryopreservedinanitrogentank.LLUISGENE/AFPviaGettyImagesKindbody,afast